CRF Health Improves Patient and Site eCOA Experience
CRF Health, the leading electronic Clinical Outcome Assessment (eCOA) solutions provider announced several innovative enhancements to their TrialMax eCOA solutions.
CRF Health, the leading electronic Clinical Outcome Assessment (eCOA) solutions provider announced several innovative enhancements to their TrialMax eCOA solutions.
CRF Health has added new usability and patient retention enhancements that improve the efficiency of collecting clinical outcome data directly from patients and sites.
Among the improved features:
- Patient and site user experience improvements through meticulous user interface design and extensive usability testing, further reducing patient and site burden
- Investigators have on-demand access to study specific training directly on the TrialMax Slate, improving site compliance by ensuring training is available when needed as a reference or for new staff supporting the trial
- Ability to send SMS and email reminders to patients across all TrialMax eCOA solutions to keep patients engaged
- The new TrialMax Slate study dashboard clearly displays the questionnaire status of all patient visits. This enhancement reduces site burden and increases the efficiency of the eCOA collection process by highlighting required and incomplete questionnaires
For more information on the enhancements to TrialMax eCOA solutions or on how CRF Health supports clinical trials by fitting into patients’ lives, visit their website (
www.crfhealth.com
).
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025